Skip to content
10-Q

Quarterly Report

CORNERSTONE THERAPEUTICS INC

0001193125-13-209793

← back to feed
Filed
May 9, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 2, 2013 26.8M sh
Shares Diluted Q1 2013 · Mar 31, 2013 30.97M sh
Shares Diluted Q1 2013 · Mar 31, 2012 25.82M sh
Capex Q1 2013 · Mar 31, 2013 $364K
Capex Q1 2013 · Mar 31, 2012 $80K
Operating Cash Flow Q1 2013 · Mar 31, 2013 $8.39M
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$2.71M
Long Term Debt Q1 2013 · Mar 31, 2013 $89.57M
Long Term Debt Q1 2013 · Dec 31, 2012 $89.54M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $63.39M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $56.25M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $74.2M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $73.97M
Stockholders Equity Q1 2013 · Mar 31, 2013 $169.63M
Stockholders Equity Q1 2013 · Dec 31, 2012 $166.17M
Current Liabilities Q1 2013 · Mar 31, 2013 $64.67M
Current Liabilities Q1 2013 · Dec 31, 2012 $66.83M
Total Liabilities Q1 2013 · Mar 31, 2013 $200.19M
Total Liabilities Q1 2013 · Dec 31, 2012 $203.2M
Current Assets Q1 2013 · Mar 31, 2013 $107.17M
Current Assets Q1 2013 · Dec 31, 2012 $102.57M
Total Assets Q1 2013 · Mar 31, 2013 $369.82M
Total Assets Q1 2013 · Dec 31, 2012 $369.38M
Eps Diluted Q1 2013 · Mar 31, 2013 $0.09
Eps Diluted Q1 2013 · Mar 31, 2012 −$0.07
Eps Basic Q1 2013 · Mar 31, 2013 $0.09
Eps Basic Q1 2013 · Mar 31, 2012 −$0.07
Sga Expense Q1 2013 · Mar 31, 2013 $13.12M
Sga Expense restated Q1 2013 · Mar 31, 2012 $10.92M
Rd Expense Q1 2013 · Mar 31, 2013 $827K
Rd Expense Q1 2013 · Mar 31, 2012 $1.05M
Net Income Q1 2013 · Mar 31, 2013 $2.42M
Net Income Q1 2013 · Mar 31, 2012 −$1.83M
Operating Income Q1 2013 · Mar 31, 2013 $4.64M
Operating Income Q1 2013 · Mar 31, 2012 −$3.04M
Cost Of Revenue Q1 2013 · Mar 31, 2013 $12.16M
Cost Of Revenue Q1 2013 · Mar 31, 2012 $8.69M
Revenue Q1 2013 · Mar 31, 2013 $37.98M
Revenue Q1 2013 · Mar 31, 2012 $22.16M